Rene Bernards serves as Executive at LIXTE BIOTECHNOLOGY HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Rene Bernards has executed 7 insider transactions totaling $89.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 3, 2023 involved purchasing 5,527 shares valued at $13.9K.
Rene Bernards currently holds 25,000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rene Bernards has been a net buyer of LIXT stock. They have purchased $89.8K and sold $0 worth of shares.
Rene Bernards's most recent insider trade was on Oct 3, 2023, when they purchased 5,527 shares at $2.51 per share.
Get notified when new Form 4 filings are submitted
| $2.51 |
| Discretionary |
| Oct 2, 2023 | LIXT | $10.2K | Purchase | 4,473 | $2.29 | Discretionary |
| Oct 2, 2023 | LIXT | $10.2K | Purchase | 4,473 | $2.29 | Discretionary |
| Dec 15, 2022 | LIXT | $7.7K | Purchase | 15,000 | $0.51 | Discretionary |
| Dec 12, 2022 | LIXT | $6.1K | Purchase | 10,000 | $0.61 | Discretionary |
| Nov 14, 2022 | LIXT | $27.8K | Purchase | 52,500 | $0.53 | Discretionary |